NO975713L - Chelaterende polymere som kontrastmidler for medisinsk billeddannelse - Google Patents

Chelaterende polymere som kontrastmidler for medisinsk billeddannelse

Info

Publication number
NO975713L
NO975713L NO975713A NO975713A NO975713L NO 975713 L NO975713 L NO 975713L NO 975713 A NO975713 A NO 975713A NO 975713 A NO975713 A NO 975713A NO 975713 L NO975713 L NO 975713L
Authority
NO
Norway
Prior art keywords
polychelating
medical imaging
contrast agents
bonds
carbon atoms
Prior art date
Application number
NO975713A
Other languages
English (en)
Other versions
NO975713D0 (no
Inventor
Kenneth Robert Hollister
Kenneth Edmond Keller
Dong Wei
Xin Peng
David Lee Ladd
Robert Allen Snow
Paul Mark Heinrichs
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO975713D0 publication Critical patent/NO975713D0/no
Publication of NO975713L publication Critical patent/NO975713L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Oppfinnelsen tilveiebringer polymere polychelateringsmidler som inneholder polymergjentagende enheter med formelen [L-Ch-L-B] (hvor Ch er en polydentat- chelateringsmiddelgruppe, L er en amid- eller esterbinding, B er en hydrofob gruppe som gir en karbonkjede med minst 4 karbonatomer mellom L-bindingene som den binder sammen), eller et salt eller chelat derav, under den forutsetning at når Ch er 2,5-biskarboksymetyl-2,5-diazaheks-1,6-diyl, er polychelateringsmidlet metalldannet med lantanid- eller manganioner, eller B gir en karbonkjede med minst 10 karbonatomer mellom L-bindingene som den binder sammen, og deres salter og chelater. De paramagnetiske polychelatene av polychelateringsmidlene i henhold til oppfinnelsen har bemerkelsesverdig høy R1-relaksivitet.
NO975713A 1995-06-07 1997-12-05 Chelaterende polymere som kontrastmidler for medisinsk billeddannelse NO975713L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,803 US5801228A (en) 1995-06-07 1995-06-07 Polymeric contrast agents for medical imaging
PCT/GB1996/001308 WO1996040274A2 (en) 1995-06-07 1996-06-03 Chelating polymers as contrast agents for medical imaging

Publications (2)

Publication Number Publication Date
NO975713D0 NO975713D0 (no) 1997-12-05
NO975713L true NO975713L (no) 1998-02-02

Family

ID=23901417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975713A NO975713L (no) 1995-06-07 1997-12-05 Chelaterende polymere som kontrastmidler for medisinsk billeddannelse

Country Status (9)

Country Link
US (1) US5801228A (no)
EP (1) EP0831930A1 (no)
JP (1) JP2001507378A (no)
KR (1) KR19990022575A (no)
CN (1) CN1192160A (no)
AU (1) AU5841596A (no)
CA (1) CA2223456A1 (no)
NO (1) NO975713L (no)
WO (1) WO1996040274A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500365A (ja) * 1993-05-20 1997-01-14 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 磁気共鳴映像法に用いる巨大分子造影剤
WO1998010797A2 (en) * 1996-09-12 1998-03-19 Nycomed Imaging As Marker compositions
WO1998028258A1 (en) 1996-12-23 1998-07-02 Bracco Research S.A. Compositions for increasing the mri contrast in visualising the digestive tract of patients
EP0977598A1 (en) * 1997-04-22 2000-02-09 Nycomed Imaging As Nmr image compounds
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6818626B1 (en) * 1998-07-17 2004-11-16 Mirus Corporation Chelating systems for use in the delivery of compounds to cells
JP2000086538A (ja) * 1998-09-17 2000-03-28 Toshihiro Akaike Ｍｒｉ用造影剤
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
AU2371400A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
CA2727746A1 (en) 1998-12-18 2000-06-22 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
WO2001087354A2 (en) * 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
BR0106717A (pt) * 2000-06-01 2002-04-16 Bristol Myers Squibb Pharma Co Compostos, composição farmacêutica e usos dos compostos de lactama inovadora
JP2004512382A (ja) * 2000-11-03 2004-04-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流および心臓炎症の２核種同時イメージング
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
JP2004537573A (ja) * 2001-08-08 2004-12-16 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流およびビトロネクチン受容体を標的とするイメージング剤の同時イメージング
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050106101A1 (en) * 2003-10-31 2005-05-19 Ajay Purohit Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
US7485283B2 (en) * 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US20060083681A1 (en) * 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
AU2006266074A1 (en) * 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
US20070202047A1 (en) * 2006-01-05 2007-08-30 Markus Wolf Polyamine-substituted ligands for use as contrast agents
RU2009125599A (ru) 2006-12-04 2011-01-20 Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс (Us) Композиции и способы лечения рака cpg-богатой днк и купредоксинами
KR20090114414A (ko) 2007-02-08 2009-11-03 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신으로 암을 예방하는 조성물과 방법
PT2257315T (pt) * 2008-02-29 2020-01-27 Lantheus Medical Imaging Inc Agentes de contraste para aplicações incluindo imagiologia de perfusão
JP5311982B2 (ja) * 2008-11-21 2013-10-09 大和製罐株式会社 イミドオリゴマー及びこれを加熱硬化させてなるポリイミド樹脂
PT2419096T (pt) 2009-04-15 2020-02-19 Lantheus Medical Imaging Inc Estabilização de composições radiofarmacêuticas utilizando ácido ascórbico
PT2534136T (pt) 2010-02-08 2017-12-15 Lantheus Medical Imaging Inc Métodos para sintetizar agentes de imagiologia, e seus intermediários
FR2983861B1 (fr) * 2011-12-09 2016-01-08 Centre Nat Rech Scient Copolymere hydrophobe visible en irm
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2018053460A1 (en) * 2016-09-19 2018-03-22 The Regents Of The University Of California Paramagnetic polymers
CN106977714A (zh) * 2017-03-03 2017-07-25 广州军区广州总医院 正电子标记纳米探针68Ga‑NOTA‑DGL‑Ac及其制备方法与用途
KR20230146177A (ko) 2022-04-11 2023-10-19 주식회사 아이디엇 파우치형 기능성 명함

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34615A (en) * 1969-06-11 1974-11-29 Stauffer Chemical Co Ethylenediaminetetraacetic acid derivatives and their preparation
US4707453A (en) * 1985-04-05 1987-11-17 Becton Dickinson And Company Vesicle including a metal marker for use in an assay
AU593611B2 (en) * 1986-02-14 1990-02-15 Nihon Medi-Physics Co., Ltd. High molecular compounds having amino groups, and their utilization
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
CS273274B1 (en) * 1988-05-11 1991-03-12 Smidrkal Jan Method of alkaline polymer amides production
US5914095A (en) * 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
GB9320277D0 (en) * 1993-10-01 1993-11-17 Nycomed Salutar Inc Chelants
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH06506449A (ja) * 1991-03-27 1994-07-21 サルター　アイエヌシー コントラスト媒体
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH06507904A (ja) * 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 磁気共鳴画像形成用の油脂可溶化合物
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
KR950703582A (ko) * 1992-10-14 1995-09-20 조이스 이. 마임스 킬레이트화 중합체(chelating polymers)
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5466439A (en) * 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5730968A (en) * 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents

Also Published As

Publication number Publication date
JP2001507378A (ja) 2001-06-05
NO975713D0 (no) 1997-12-05
WO1996040274A2 (en) 1996-12-19
MX9709787A (es) 1998-07-31
AU5841596A (en) 1996-12-30
WO1996040274A3 (en) 1997-02-13
KR19990022575A (ko) 1999-03-25
CN1192160A (zh) 1998-09-02
EP0831930A1 (en) 1998-04-01
CA2223456A1 (en) 1996-12-19
US5801228A (en) 1998-09-01

Similar Documents

Publication Publication Date Title
NO975713L (no) Chelaterende polymere som kontrastmidler for medisinsk billeddannelse
IE893067L (en) Chelate compositions
BRPI0111596B8 (pt) Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
ES506414A0 (es) Procedimiento para la preparacion de dipeptidos carboxi-alquilicos.
SI0646595T1 (en) Nucleic acid binding oligomers having C-branches for therapy and diagnosis
IL90409A0 (en) Macrocyclic chelates
AU7115191A (en) Biphenylylaliphathylamino compounds, their use as antihypertensives, pharmaceutical compositions and processes for their manufacture
EP1116752A4 (en) POLYCETONE SOLUTION
ATE196305T1 (de) Wasserlösliche polymere und diese enthaltende zusammensetzungen
EP2201945A3 (en) Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
EP1071474A4 (en) SUBSTITUTED PORPHYRINE
KR970704864A (ko) 세정제 조성물
WO1996016079A3 (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
DE59605649D1 (de) Polymerisationsfähige derivate von polyamiden
GB2093458B (en) Polymerisable tertiary phosphate derivatives useful as fillers for human hard tissues
MX9604367A (es) Hidroxipiridinonas novedosas.
PL354644A1 (en) Solubilisation of 1,3,4-triazine derivatives by means of esters of n-actlamino acids
DE59408308D1 (de) Nukleinsäure-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
EP0833825A4 (en) 6-CARBOXAMIDO-DIHYDROPYRAN DERIVATIVES
ATE434406T1 (de) Manganzusammensetzungen und verfahren für mri
AU1198897A (en) 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
NO20005751L (no) Merkede analoger av glutamin og lysin
RU98113782A (ru) Комплексы каскадных полимеров, способы их получения и содержащие их лекарственные средства
NO932526L (no) Fremgangsmaate for stabilisering av jern(hydr) oksyder i vann produ sert paa oljefelt
PL357647A1 (en) Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors